CRIS Curis Inc

Curis Inc is a biotechnology company engaged in developing and commercializing drug candidates for the treatment of human cancers.

$11.50  -0.33 (-2.79%)
As of 04/09/2021 15:59:50 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  02/12/2001
Outstanding shares:  91,519,060
Average volume:  2,383,221
Market cap:   $1,052,469,190
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    231269200
ISIN:        US2312692005
Sedol:      BDGGJ94
Valuation   (See tab for details)
PE ratio:   -35.19
PB ratio:   8.05
PS ratio:   97.14
Return on equity:   -22.89%
Net income %:   -276.03%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy